Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Asclemed USA Inc. recalls Duloxetine DR Capsules

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
CGMP Deviations; presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-nitroso-duloxetine, above the FDA acceptable intake limit.
Products
  • Duloxetine DR Capsules
Where it was sold

US Nationwide.

Nationwide

Units affected
50 bottles
About this recall
Duloxetine DR Capsules, 30 mg, 30 count bottles, Rx, Relabeled by: Enovachem Pharmaceuticals, Torrance, CA 90501, NDC 76420-634-30, Marketed by: Ajanta Pharma USA Inc.